Published: May 30, 2026
Written by Klarity Editorial Team
Published: May 30, 2026

If you’re struggling with binge eating disorder (BED), you’ve likely wondered whether you can get help—and medication—without having to visit a doctor’s office in person. The good news: Yes, you can receive medication for binge eating disorder through telehealth in 2025 and beyond. The landscape of virtual mental health care has matured significantly, with clear legal frameworks now in place that make treatment more accessible than ever.
This comprehensive guide will walk you through everything you need to know about getting BED medication via telehealth, including which medications are available, what the laws say, and how to access safe, effective treatment from the comfort of your home.
Binge eating disorder is the most common eating disorder in the United States, characterized by recurrent episodes of eating large quantities of food in a short period while feeling a loss of control. Unlike bulimia, BED doesn’t involve purging behaviors. According to DSM-5 criteria, diagnosis requires binge eating episodes at least once weekly for three months, accompanied by feelings of distress about the behavior.
While therapy—particularly cognitive behavioral therapy (CBT)—remains the gold standard for BED treatment, medication can play an important supporting role. Two medications are commonly prescribed off-label for BED through telehealth platforms:
Originally FDA-approved for seizures and migraine prevention, topiramate has shown promise in reducing binge frequency and supporting impulse control. Clinical research suggests it may help with the compulsive aspects of binge eating, though it requires careful titration and monitoring for side effects like cognitive changes and tingling sensations.
This antidepressant, approved for depression and smoking cessation, has been studied for binge eating disorder with some patients experiencing reduced binge episodes. It works on dopamine and norepinephrine pathways, which may help address the reward-seeking behaviors associated with binge eating.
Important note: These are non-controlled substances, which is crucial for telehealth accessibility. The only FDA-approved medication specifically for BED is Vyvanse (lisdexamfetamine), a controlled stimulant that faces stricter telehealth prescribing requirements and is generally not available through remote-only consultations.
The legal framework for telehealth prescribing depends heavily on whether a medication is classified as ‘controlled’ under federal law. Here’s where BED patients have an advantage:
Topamax and Wellbutrin are not controlled substances, meaning they were never subject to the Ryan Haight Act—the 2008 federal law that originally required an in-person medical evaluation before prescribing controlled medications via telemedicine. For non-controlled medications like these, there has never been a federal barrier to telehealth prescribing, provided the prescriber follows standard medical care practices.
While the pandemic-era emergency flexibilities primarily affected controlled substances, they’ve created a broader culture of telehealth acceptance. As of January 2026, the DEA has extended telehealth prescribing waivers for controlled substances through December 31, 2026, while permanent regulations are finalized. This demonstrates the federal government’s commitment to maintaining telehealth access even as temporary emergency measures wind down.
For your BED medications, this means the telehealth infrastructure built during the pandemic—including secure video platforms, electronic prescribing systems, and remote monitoring protocols—remains fully operational and legally supported.
While federal law sets the baseline, individual states can add their own requirements. The good news is that most states have permanently adopted telehealth-friendly policies for non-controlled medications. Here’s what the landscape looks like across key states:
California, New York, Delaware, Florida, Texas, Michigan, Wisconsin, and South Carolina have no mandatory in-person visit requirements for prescribing non-controlled medications like Topamax or Wellbutrin via telehealth. In these states, a comprehensive video consultation can serve as the complete medical evaluation needed to initiate treatment.
California went particularly far in 2025 with AB 1503, which explicitly allows asynchronous telehealth (such as detailed online questionnaires) to constitute a valid medical exam if it meets the appropriate standard of care—making access even more flexible.
Alabama, Georgia, and New Hampshire ask that patients receiving ongoing telehealth care have at least one in-person evaluation within 12 months of continuous treatment. However, this requirement can often be satisfied by seeing any healthcare provider in person (such as your primary care doctor), not necessarily the telehealth prescriber. Initial treatment can still start fully online.
For example, in Alabama, if you have more than four telehealth visits for the same condition within 12 months, an in-person visit should occur within that year. In Georgia, providers must ‘attempt’ an annual in-person exam for ongoing telemedicine patients. These rules acknowledge that some conditions benefit from periodic hands-on evaluation while preserving remote access for initial and routine care.
Most states require prescribers to check their Prescription Drug Monitoring Program database before prescribing controlled substances (opioids, stimulants, benzodiazepines). Since Topamax and Wellbutrin are not controlled, these mandatory PMP checks don’t apply. Your provider may still review your medication history as a best practice to ensure safety and avoid drug interactions, but it’s not a legal requirement for these specific medications.
The answer depends on both the type of provider and your state’s scope-of-practice laws:
Medical doctors and doctors of osteopathy can prescribe BED medications via telehealth in all 50 states, provided they’re licensed in the state where you’re located during the consultation.
As of 2025, 34 states plus Washington D.C. grant nurse practitioners Full Practice Authority, meaning they can evaluate, diagnose, and prescribe independently without physician oversight. This list has grown rapidly, with Michigan, Wisconsin, Louisiana, and Kansas joining the ranks in 2023-2025.
In Full Practice Authority states like California, New York, or New Hampshire, an NP working with a telehealth platform like Klarity Health can manage your entire BED treatment without needing a physician’s signature or supervision.
In other states—including Florida, Texas, Georgia, and Alabama—NPs must work under a collaborative practice agreement with a physician. This doesn’t mean you’ll see both providers; it’s a behind-the-scenes regulatory requirement. The NP conducts your evaluation and prescribes your medication, but they do so under a formal agreement with a supervising physician.
PAs can prescribe these medications in all states but typically work under physician supervision (the degree of supervision varies by state). In practice, this rarely affects your care experience—your PA provider handles your consultation and treatment plan just like any other prescriber.
Bottom line: Whether you see an MD, DO, NP, or PA through telehealth, all can legally prescribe Topamax or Wellbutrin for BED, subject to their state’s supervision requirements.
A legitimate telehealth evaluation for binge eating disorder should be thorough and patient-centered. Here’s what a quality consultation looks like:
Your provider will ask detailed questions about your eating patterns, including:
This comprehensive evaluation ensures you meet DSM-5 criteria for BED and that medication is appropriate for your situation.
Your provider will review:
Reputable telehealth platforms will verify your identity and confirm your physical location at the time of the appointment. This isn’t invasive—it’s a regulatory requirement ensuring the provider is licensed in your state and can legally treat you. It also helps prevent fraud and prescription diversion.
Your provider should explain:
Red flags to watch for: If a telehealth service promises a prescription before proper evaluation, skips over discussing therapy or lifestyle modifications, or rushes through the assessment in under 15 minutes, that’s concerning. Quality BED care requires time, thoroughness, and individualized treatment planning.
Telehealth is remarkably effective for many patients, but certain situations require in-person evaluation or are contraindications for these specific medications:
A responsible telehealth provider will screen for these conditions and refer you to in-person care when appropriate. This isn’t a limitation of telehealth—it’s good medicine.
Both topiramate and bupropion require careful dose adjustments:
Topiramate typically starts at 25-50 mg daily and is gradually increased over several weeks to minimize side effects like cognitive slowing or tingling. Therapeutic doses for BED range from 75-200 mg daily, but this is highly individualized.
Bupropion usually begins at 150 mg daily (sustained or extended-release formulations) and may increase to 300 mg after several weeks if needed and tolerated. Immediate-release formulations require more frequent dosing.
A typical telehealth treatment plan includes:
Your provider should track:
Many telehealth platforms, including Klarity Health, use secure messaging between visits so you can report concerns without waiting for your next scheduled appointment.
Since these are non-controlled medications, your provider can authorize refills for up to one year in most states (specific limits vary). However, refills are typically contingent on keeping your follow-up appointments. This ensures ongoing monitoring and adjustment of your treatment plan as needed.
While medication can help reduce binge frequency, it’s most effective as part of a comprehensive treatment approach. Research consistently shows that cognitive behavioral therapy (CBT) specifically designed for eating disorders produces the best long-term outcomes.
Quality telehealth platforms often facilitate this integrated approach. At Klarity Health, for example, providers can prescribe medication while coordinating with therapists who specialize in eating disorders, creating a team-based care model—all accessible remotely.
Additional supportive treatments include:
Your prescriber should discuss these options and help connect you to resources, not just hand you a prescription.
The telehealth industry has grown exponentially, but quality varies. Recent enforcement actions—like the 2024 federal indictment of executives from a telehealth ADHD company for unsafe stimulant prescribing—underscore the importance of choosing carefully.
Thorough evaluations: Initial consultations should be 30+ minutes with comprehensive history-taking, not a quick questionnaire leading to automatic prescription.
Licensed providers in your state: Verify that your provider holds an active license in the state where you’re physically located during the appointment.
Transparent about limitations: Reputable services clearly state what they will and won’t prescribe (for example, most legitimate platforms don’t prescribe controlled stimulants for BED via telehealth-only consultations).
Integration with pharmacies: Prescriptions should be sent electronically to legitimate pharmacies (your choice of local or mail-order), not shipped directly from the telehealth company.
Follow-up requirements: Quality platforms require scheduled follow-ups and won’t just send indefinite refills without monitoring.
Clear pricing and insurance: Providers should be upfront about costs. Klarity Health, for instance, accepts both insurance and offers transparent cash-pay pricing, making treatment accessible regardless of coverage.
Multidisciplinary care: The best services facilitate access to therapy, nutrition counseling, and other supports—not just medication.
Most health insurance plans now cover telehealth mental health services at the same rate as in-person visits, a change that became permanent in many states post-pandemic. Your consultation and medication management visits should be covered subject to your plan’s mental health benefits (copays, deductibles, etc.).
Medication costs depend on your pharmacy benefit. Both topiramate and bupropion are available as generics, making them relatively affordable—often $10-40/month with insurance, sometimes less with GoodRx or similar discount programs if you’re paying cash.
If you don’t have insurance or prefer not to use it, many telehealth platforms offer transparent cash pricing. Klarity Health, for example, provides clear upfront costs for consultations and accepts both insurance and self-pay, giving you flexibility in how you access care.
Initial evaluation visits typically range from $99-299 cash-pay, with follow-ups around $79-150. These prices are often competitive with in-person specialist copays, especially considering you save time and travel costs.
Legitimate telehealth platforms must comply with HIPAA (Health Insurance Portability and Accountability Act), ensuring your health information is protected. This includes:
Your binge eating disorder diagnosis and treatment are part of your confidential medical record. Providers cannot share this information without your written permission, except in specific circumstances (like mandatory reporting of child abuse or imminent safety threats).
The legal and technological infrastructure for telehealth mental health care is now firmly established. While federal regulators continue to refine policies around controlled substances (with a final DEA rule expected by late 2026), access to non-controlled medications for conditions like BED remains secure and well-supported.
Several trends suggest telehealth for eating disorders will continue expanding:
Growing NP independence: As more states grant nurse practitioners full practice authority, access to prescribers will increase, particularly in underserved rural areas.
Integrated care models: Platforms are increasingly offering combined medication management, therapy, and nutritional counseling—addressing BED holistically.
Improved technology: Better video platforms, remote monitoring tools, and even apps that track eating patterns are making telehealth more effective.
Reduced stigma: Virtual care removes some barriers for people who feel embarrassed seeking help for eating disorders in person.
Insurance parity: Continued regulatory support for telehealth reimbursement ensures affordability.
If you’re ready to explore medication treatment for binge eating disorder via telehealth:
Research platforms that specialize in mental health and eating disorders (Klarity Health offers psychiatry services with providers experienced in BED treatment)
Verify provider licensing in your state and check if they accept your insurance
Schedule an initial evaluation and prepare to discuss your eating patterns, medical history, and treatment goals honestly
Be ready for a thorough assessment—quality care takes time
Discuss all treatment options, including therapy, before deciding on medication
Commit to follow-up—medication works best with consistent monitoring and support
Consider therapy alongside medication for the most comprehensive treatment
The question ‘Can you get binge eating disorder medication via telehealth?’ has a clear answer: Yes, absolutely. The regulatory framework as of 2025-2026 fully supports remote prescribing of non-controlled medications like Topamax and Wellbutrin for BED. Most states have eliminated in-person requirements for initial consultations, and the federal government has demonstrated its commitment to maintaining telehealth access even as pandemic emergency measures end.
Quality telehealth platforms now offer comprehensive BED treatment that rivals—and in some ways exceeds—traditional in-person care by providing greater convenience, reduced stigma, and often faster access to specialized providers. When you choose a reputable service that conducts thorough evaluations, monitors your progress carefully, and integrates medication with therapy and other supports, you’re receiving evidence-based treatment that can genuinely help reduce binge eating episodes and improve your relationship with food.
The key is choosing wisely. Look for providers who take time to understand your unique situation, explain treatment options clearly, monitor your progress consistently, and prioritize your safety above quick prescriptions. Platforms like Klarity Health meet these standards by offering access to licensed psychiatrists and nurse practitioners who specialize in eating disorders, transparent pricing that accepts both insurance and cash payment, and appointment availability that fits your schedule—all while maintaining the highest standards of medical care and regulatory compliance.
If you’re struggling with binge eating disorder, you don’t have to continue suffering or navigate complex healthcare systems to get help. Effective treatment is available from the comfort and privacy of your home, backed by a robust legal framework and delivered by qualified, caring providers who understand eating disorders.
Take that first step. Schedule a consultation, be honest about your struggles, and give yourself the opportunity to experience relief from binge eating. Thousands of people have successfully begun their recovery journey through telehealth—and with the right support, you can too.
Verified as of: January 4, 2026
DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.
States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.
Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.
Citations:
U.S. Department of Health and Human Services. (2026). ‘DEA Extends Telemedicine Prescribing Flexibilities Through 2026.’ HHS.gov Press Release. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard Mullin Richter & Hampton LLP. (2025). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Sheppard Health Law Blog. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Center for Connected Health Policy. (2025). ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing.’ CCHP Telehealth Policy Database. https://www.cchpca.org/topic/online-prescribing/
Health Jobs Nationwide. (2025). ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ HJN Blog. https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
National Library of Medicine/DailyMed. (2024). ‘Bupropion Hydrochloride Extended-Release Tablets – FDA Label.’ DailyMed Drug Information. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display
Find the right provider for your needs — select your state to find expert care near you.